ABCB1 and acute myeloid leukemia: The molecular mechanisms that cause therapy failure leading to an unfavorable prognosis in AML are still not fully understood and are one of the most difficult obstacles in therapy [8].One of the common mechanisms for treatment failure is overexpression of drug resistance genes (MDR-1/ABCB1: ATP-binding cassette transporters) [9, 10].